NCT00685061View on ClinicalTrials.gov

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2005

Conditions
Renal Transplantation
Interventions
DRUG

Thymoglobulin

Induction

DRUG

Campath-1H

Induction

DRUG

Daclizumab

Induction

Trial Locations (1)

33136

University of Miami Division of Transplantation, Miami

All Listed Sponsors
lead

University of Miami

OTHER

NCT00685061 - Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation | Biotech Hunter | Biotech Hunter